Kang Leaving CMS For CIGNA; Agency Begins Search For Replacement
This article was originally published in The Gray Sheet
Executive Summary
Robert Streimer is expected to take over as interim acting director of Office of Clinical Standards & Quality at the Centers for Medicare & Medicaid Services when current director Jeffrey Kang, MD steps down in early May
You may also be interested in...
SACGT Query: How Does Access to Genetic Test Services Influence Test Use?
The HHS Secretary's Advisory Committee on Genetic Testing is asking the Institute of Medicine to issue a report on the role of genetic counseling and education in securing private coverage and Medicare reimbursement for genetic tests
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.